Discontinuing VEGF-targeted therapy for progression or toxicity affects outcomes of second-line therapies in mRCC

Comparing adjuvant radiotherapy plus chemo vs. adjuvant chemo following cystectomy for bladder cancer

Molecular genetics of testicular cancer: What does the clinician need to know?

Atezolizumab for platinum-treated locally advanced or metastatic urothelial carcinoma

Healthcare and QoL burden of symptomatic skeletal events in CRPC with bone mets

Regular aspirin use may reduce risk of dying from prostate cancer

Brentuximab vedotin as salvage therapy for men with relapsed germ-cell tumours

Actionable targets in patients with cisplatin-resistant advanced germ cell tumours

The work and aims of the Association of Cancer Physicians

Breast cancer screening in Morocco

Medical cancer prevention

Global cancer partnership